Analysis of Healthcare-Associated Infections in COVID-19 patients admitted to an Intensive Care Unit

Authors

DOI:

https://doi.org/10.33448/rsd-v12i5.41772

Keywords:

Cross Infection; COVID-19; SARS-CoV-2; Intensive Care Units; Catheter-Associated Infections; Infection Control.

Abstract

Introduction: Healthcare-associated infections (HAIs) are a major public health problem. Objective: To evaluate the profile of SAIs in patients with COVID-19 admitted to the intensive care unit (ICU) in a public hospital in southern Brazil. Method: Cross-sectional, retrospective study, conducted between March 2020 to October 2021, of patients with COVID-19 hospitalized in ICU with IRAS. Results: The main infection was ventilator-associated pneumonia (230 cases), followed by urinary tract infections (160 cases) and bloodstream infections (103 cases), associated with the presence of catheter. Regarding the main microorganisms, the high prevalence of multidrug-resistant Acinetobacter baumannii (112 cases) was noteworthy in ventilator-associated pneumonia, with an increasing increase in the analyzed period. The expressiveness of fungal infections, especially Candida albicans, was evidenced. Patients with ventilator-associated pneumonia had lower mortality rates (OR= 0.31; p= 0.034), which increased significantly with increasing days of ICU stay (OR= 3.02; p= 0.0000007). The profile of the patients was mainly male, with significant use of antimicrobials and antifungals, high degree of pulmonary impairment, with evolution to death. Among the predictors of mortality, the most impacting was acute renal failure (OR= 4.45; p=0.0002) and the least related was pulmonary thromboembolism (OR=0.47; p= 0.0167).  Conclusion: The high percentage of bacterial and fungal IRAS was evidenced. The highest mortality predictor was acute renal failure, while the lowest mortality was pulmonary thromboembolism.

References

ANVISA (2021). Nota técnica GVIMS/GGTES Nº 07/2021: Critérios diagnósticos das Infecções Relacionadas à Assistência à Saúde (IRAS): notificação nacional obrigatória para o ano de 2022. Ministério da Saúde. https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/notas-tecnicas/nota-tecnica-gvims-ggtes-no-07-2021-criterios-diagnosticos-das-infeccoes-relacionadas-a-assistencia-a-saude-iras-notificacao-nacional-obrigatoria-para-o-ano-de-2022/view.

Baker, M. A., Sands, K. E., Huang, S. S., Kleinman, K., Septimus, E. J., Varma, N., Blanchard, J., Poland, R. E., Coady, M. H., Yokoe, D. S., Fraker, S., Froman, A., Moody, J., Goldin, L., Isaacs, A., Kleja, K., Korwek, K. M., Stelling, J., & Clark, A. (2022). The impact of Coronavirus disease 2019 (COVID-19) on healthcare-associated infections. Clinical Infectious Diseases, 74(10), 1748–1754. https://doi.org/10.1093/cid/ciab688

Buetti, N., Ruckly, S., de Montmollin, E., Reignier, J., Terzi, N., Cohen, Y., Shiami, S., Dupuis, C., & Timsit, J. F. (2021). COVID-19 increased the risk of ICU-acquired bloodstream infections: a case–cohort study from the multicentric OUTCOMEREA network. Intensive Care Medicine, 47(2), 180–187. https://doi.org/10.1007/s00134-021-06346-w

Cucinotta D., & Vanelli M. (2020). WHO Declares COVID-19 a Pandemic. Acta Biomed 91(1), 157-160. https://doi.org/10.23750/abm.v91i1.9397

Dessie, Z. G., & Zewotir, T. (2021). Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infectious Diseases, 21(1). https://doi.org/10.1186/s12879-021-06536-3

Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., Merson, L., Lee, J., Plotkin, D., Sigfrid, L., Halpin, S., Jackson, C., Gamble, C., Horby, P. W., Nguyen-Van-Tam, J. S., … & Semple, M. G. (2020). Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. The BMJ, 369. https://doi.org/10.1136/bmj.m1985

Durán-Manuel, E. M., Cruz-Cruz, C., Ibáñez-Cervantes, G., Bravata-Alcántara, J. C., Sosa-Hernández, O., Delgado-Balbuena, L., León-García, G., Cortés-Ortíz, I. A., Cureño-Díaz, M. A., Castro-Escarpulli, G., Vélez-Reséndiz, J. M., & Bello-López, J. M. (2021). Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19. Journal of Infection in Developing Countries, 15(1), 58–68. https://doi.org/10.3855/jidc.13545

Fumagalli, J., Panigada, M., Klompas, M., & Berra, L. (2022). Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients. Current Opinion Critical Care. 28, 74-82. https://doi.org/10.1097/MCC.0000000000000908

Garcia-Vidal, C., Sanjuan, G., Moreno-García, E., Puerta-Alcalde, P., Garcia-Pouton, N., Chumbita, M., Fernandez-Pittol, M., Pitart, C., Inciarte, A., Bodro, M., Morata, L., Ambrosioni, J., Grafia, I., Meira, F., Macaya, I., Cardozo, C., Casals, C., Tellez, A., Castro, P. & Torres, A. (2021). Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection, 27(1), 83–88. https://doi.org/10.1016/j.cmi.2020.07.041

Grasselli, G., Scaravilli, V., Mangioni, D., Scudeller, L., Alagna, L., Bartoletti, M., Bellani, G., Biagioni, E., Bonfanti, P., Bottino, N., Coloretti, I., Cutuli, S. L., De Pascale, G., Ferlicca, D., Fior, G., Forastieri, A., Franzetti, M., Greco, M., Guzzardella, A., & Bandera, A. (2021). Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest Infetctions, 160(2), 454–465. https://doi.org/10.1016/j.chest.2021.04.002

Gottesman, T., Fedorowsky, R., Yerushalmi, R., Lellouche, J., & Nutman, A. (2021). An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital. Infection Prevention in Practice, 3(1), 100113. https://doi.org/10.1016/J.INFPIP.2021.100113

Kariyawasam, R. M., Julien, D. A., Jelinski, D. C., Larose, S. L., Rennert-May, E., & Barkema, H. W. (2022). Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021). Antimicrobial Resistance and Infection Control, 11(1), 45. https://doi.org/10.1186/s13756-022-01085-z

Ko, J. J., Wu, C., Mehta, N., Wald-Dickler, N., Yang, W., & Qiao, R. (2021). A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19. Journal of Intensive Care Medicine, 36(6), 673–680. https://doi.org/10.1177/0885066621994057

Langford, B. J., So, M., Raybardhan, S., Leung, V., Westwood, D., MacFadden, D. R., Soucy, J. P. R., & Daneman, N. (2020). Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. In Clinical Microbiology and Infection (Vol. 26, Issue 12, pp. 1622–1629). Elsevier B.V. https://doi.org/10.1016/j.cmi.2020.07.016

Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020). Co-infections in people with COVID-19: a systematic review and meta-analysis. Journal of Infectology 81, 266-275. https://doi.org/10.1016/j.jinf.2020.05.046

Lastinger, L., Alvarez, C., Kofman, A., Konnor, R., Kuhar, D., Nkwata, A., & Dudeck, M. (2022). Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic. Infection Control & Hospital Epidemiology, 1-5. doi:10.1017/ice.2022.116

Maes, M., Higginson, E., Pereira-Dias, J., Curran, M. D., Parmar, S., Khokhar, F., Cuchet-Lourenço, D., Lux, J., Sharma-Hajela, S., Ravenhill, B., Hamed, I., Heales, L., Mahroof, R., Solderholm, A., Forrest, S., Sridhar, S., Brown, N. M., Baker, S., Navapurkar, V., …& Conway Morris, A. (2021). Ventilator-associated pneumonia in critically ill patients with COVID-19. Critical Care, 25(1). https://doi.org/10.1186/s13054-021-03460-5

Nebreda-Mayoral, T., Miguel-Gómez, M. A., March-Rosselló, G. A., Puente-Fuertes, L., Cantón-Benito, E., Martínez-García, A. M., Muñoz-Martín, A. B., & Orduña-Domingo, A. (2022). Infección bacteriana/fúngica en pacientes con COVID-19 ingresados en un hospital de tercer nivel de Castilla y León, España. Enfermedades Infecciosas y Microbiología Clínica, 40(4), 158–165. https://doi.org/10.1016/J.EIMC.2020.11.003

Nedel, W., Silveira, F., da Silva, C. F., & Lisboa, T. (2022). Bacterial infection in coronavirus disease 2019 patients: co-infection, super-infection and how it impacts on antimicrobial use. Current Opinion Critical Care, 28(5), 463-469. https://doi.org/10.1097/MCC.0000000000000975

O’Toole, R. (2021). The Interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol and Infect 27(12), 1772-1776. https://doi.org/10.1016/j.cmi.2021.06.001

Pascale, R., Bussini, L., Gaibani, P., Bovo, F., Fornaro, G., Lombardo, D., Ambretti, S., Pensalfine, G., Appolloni, L., Bartoletti, M., Tedeschi, S., Tumietto, F., Lewis, R., Viale, P., & Giannella, M. (2022). Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study. Infection Control and Hospital Epidemiology, 43(4), 461–466. https://doi.org/10.1017/ice.2021.144

Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020). Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. Clinical Infectious Diseases, 71(9), 2459–2468. https://doi.org/10.1093/cid/ciaa530

Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. The journal of Intectious Diseases, 197(8), 1079-1081. https://doi.org/10.1086/533452

Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., Barnaby, D. P., Becker, L. B., Chelico, J. D., Cohen, S. L., Cookingham, J., Coppa, K., Diefenbach, M. A., Dominello, A. J., Duer-Hefele, J., Falzon, L., Gitlin, J., Hajizadeh, N., Harvin, T. G., & Zanos, T. P. (2020). Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA - Journal of the American Medical Association, 323(20), 2052–2059. https://doi.org/10.1001/jama.2020.6775

Rouzé, A., Martin-Loeches, I., Povoa, P., Makris, D., Artigas, A., Bouchereau, M., Lambiotte, F., Metzelard, M., Cuchet, P., Boulle Geronimi, C., Labruyere, M., Tamion, F., Nyunga, M., Luyt, C. E., Labreuche, J., Pouly, O., Bardin, J., Saade, A., Asfar, P., & Cilloniz, C. (2021). Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Medicine, 47(2), 188–198. https://doi.org/10.1007/s00134-020-06323-9

Russell, C. D., Fairfield, C. J., Drake, T. M., Turtle, L., Seaton, R. A., Wootton, D. G., Sigfrid, L., Harrison, E. M., Docherty, A. B., de Silva, T. I., Egan, C., Pius, R., Hardwick, H. E., Merson, L., Girvan, M., Dunning, J., Nguyen-Van-Tam, J. S., Openshaw, P. J. M., Baillie, J. K., & Young, P. (2021). Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. The Lancet Microbe, 2(8), e354–e365. https://doi.org/10.1016/S2666-5247(21)00090-2

Russo, A., Gavaruzzi, F., Ceccarelli, G., Borrazzo, C., Oliva, A., Alessandri, F., Magnanimi, E., Pugliese, F., & Venditti, M. (2022). Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection, 50(1), 83–92. https://doi.org/10.1007/s15010-021-01643-4

Shinohara, D.R., Saalfeld, S. M. S., Martinez, H. V., Altafini, D. D., Costa, B. B., Fedrigo, N. H., & Tognim, M. C. B. (2021). Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavírus disease 2019 (COVID-19) – specific intensive care unit. Infection Control & Hospital Epidemiology, 43, 815-817. https://doi.org/10.1017/ice.2021.98

Singulani, J. L., Silva, D. L., Lima, C. M., Magalhães, V. C. R., Baltazar, L. M., Peres, N. T. A., Caligiorne, R. B., Moura, A. S., Santos, A. R. O., Fereguetti, T., Martins, J. C., Rabelo, L. F., Lyon, A. C., Johann, S., Falcão, J. P., & Santos, D. A. (2022b). The impact of COVID-19 on antimicrobial prescription and drug resistance in fungi and bacteria. Brazilian Journal of Microbiology, 53(4), 1925–1935. https://doi.org/10.1007/s42770-022-00818-x

Song, G., Liang, G., & Liu, W. (2020). Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. In Mycopathologia. 185(4), 599–606. Springer. https://doi.org/10.1007/s11046-020-00462-9

Tomazini, B. M., Maia, I. S., Cavalcanti, A. B., Berwanger, O., Rosa, R. G., Veiga, V. C., Avezum, A., Lopes, R. D., Bueno, F. R., Silva, M. V. A. O., Baldassare, F. P., Costa, E. L. V., Moura, R. A. B., Honorato, M. O., Costa, A. N., Damiani, L. P., Lisboa, T., Kawano-Dourado, L., Zampieri, F. G., … & Azevedo, L. C. P. (2020). Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients with Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA - Journal of the American Medical Association, 324(13), 1307–1316. https://doi.org/10.1001/jama.2020.17021

Welte, T., Ambrose, L. J., Sibbring, G. C., Sheikh, S., Mullerova, H, & Sabir, I. (2021). Current evidence for COVID-19 therapies: a systematic literature review. European Respiratory Review. https://doi.org/10.1183/16000617.0384-2020

World Health Organization (2016). Health care without avoidable infections: The critical role of infection prevention and control. World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/246235/WHO-HIS-SDS-2016.10-eng.pdf.

World Health Organization (2021). Timeline WHO’s COVID-19 response. World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!.

World Health Organization. (2023). Weekly Epidemiological Update on COVID-19. World Health Organization. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---4-january-2023

Downloads

Published

26/05/2023

How to Cite

KARAS, B.; SOUZA, A. C. M. F. de .; JUPEN, G. A. .; RICKLI, G. Ângelo F. .; ITO, C. A. S. .; MONTES, E. G. .; BAIL, L. .; GASPAR, M. D. da R. . Analysis of Healthcare-Associated Infections in COVID-19 patients admitted to an Intensive Care Unit. Research, Society and Development, [S. l.], v. 12, n. 5, p. e25412541772, 2023. DOI: 10.33448/rsd-v12i5.41772. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/41772. Acesso em: 19 apr. 2024.

Issue

Vol. 12 No. 5

Section

Health Sciences

License

Copyright (c) 2023 Bruna Karas; Ana Carolina Mello Fontoura de Souza; Gabriela Alves Jupen; Guilherme Ângelo Faria Rickli; Carmen Antônia Sanches Ito; Elisangela Gueiber Montes; Larissa Bail; Maria Dagmar da Rocha Gaspar

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.